Skip to content

NEMAURA MEDICAL INC.: 10-Q filed 2019-11-08

What NEMAURA MEDICAL INC. reported in its quarterly report filed 2019-11-08 (fiscal Q2 2020): 34 published measures, 93 facts as tagged in accession 0001079973-19-000567.

This filing

Form
10-Q (quarterly report)
Filed
2019-11-08
Fiscal period
fiscal Q2 2020
Accession
0001079973-19-000567 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NEMAURA MEDICAL INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2019-09-302,703,616USD
At 2019-03-314,763,715USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2019-09-302,507,303USD
At 2019-03-312,536,811USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2019-09-30196,313USD
At 2019-06-301,308,378USD
At 2019-03-312,226,904USD
At 2018-09-302,050,446USD
At 2018-06-303,113,203USD
At 2018-03-314,110,965USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2019-09-301,771,115USD
At 2019-03-313,740,664USD
At 2018-09-30526,148USD
At 2018-03-31822,335USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-1,117,040USD92
2019-04-01 to 2019-09-30-2,368,305USD183
2018-07-01 to 2018-09-30-1,139,275USD92
2018-04-01 to 2018-09-30-1,902,429USD183

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-04-01 to 2019-09-30-1,862,717USD183
2018-04-01 to 2018-09-30-1,541,667USD183

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2019-04-01 to 2019-09-30133,716USD183
2018-04-01 to 2018-09-300USD183

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-07-01 to 2019-09-300USD92
2019-04-01 to 2019-09-300USD183
2018-07-01 to 2018-09-300USD92
2018-04-01 to 2018-09-300USD183

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-04-01 to 2019-09-30168,917USD183
2018-04-01 to 2018-09-30500USD183

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-04-01 to 2019-09-30-162,026USD183
2018-04-01 to 2018-09-301,316,934USD183

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2019-09-30-15,794,184USD
At 2019-03-31-13,425,879USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2019-07-01 to 2019-09-30208,021,967shares92
2019-04-01 to 2019-09-30207,929,675shares183
2018-07-01 to 2018-09-30205,003,261shares92
2018-04-01 to 2018-09-30155,957,363shares183

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2019-09-30162,677USD
At 2019-03-3156,871USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-04-01 to 2019-09-30277,664USD183
2018-04-01 to 2018-09-30114,500USD183

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-1,117,040USD92
2019-04-01 to 2019-09-30-2,372,231USD183
2018-07-01 to 2018-09-30-1,147,357USD92
2018-04-01 to 2018-09-30-1,919,320USD183

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2019-09-302,343,045USD
At 2019-03-314,515,160USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2019-09-301,336,903USD
At 2019-03-311,298,961USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2019-09-30214,121USD
At 2019-03-31161,348USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2019-09-30197,894USD
At 2019-03-31191,684USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2019-07-01 to 2019-09-301,117,040USD92
2019-04-01 to 2019-09-302,372,231USD183
2018-07-01 to 2018-09-301,147,357USD92
2018-04-01 to 2018-09-301,919,320USD183

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2019-09-30195,974USD
At 2019-03-3138,036USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2019-07-01 to 2019-09-30462,517USD92
2019-04-01 to 2019-09-301,018,699USD183
2018-07-01 to 2018-09-30622,282USD92
2018-04-01 to 2018-09-301,051,821USD183

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2019-09-30208,029,304shares
At 2019-03-31207,655,916shares
At 2018-03-3167,676,000shares

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2019-09-30-363,040USD
At 2019-03-31-339,888USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2019-09-30196,313USD
At 2019-03-312,226,904USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2019-09-30360,571USD
At 2019-03-31248,555USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2019-04-01 to 2019-09-30-2,368,305USD183
2018-04-01 to 2018-09-30-1,902,429USD183

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-1,124,441USD92
2019-04-01 to 2019-09-30-2,391,457USD183
2018-07-01 to 2018-09-30-1,177,758USD92
2018-04-01 to 2018-09-30-2,175,521USD183

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2019-07-01 to 2019-09-30-1,117,040USD92
2019-04-01 to 2019-09-30-2,368,305USD183
2018-07-01 to 2018-09-30-1,139,275USD92
2018-04-01 to 2018-09-30-1,902,428USD183

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-07-01 to 2019-09-30654,523USD92
2019-04-01 to 2019-09-301,353,532USD183
2018-07-01 to 2018-09-30525,075USD92
2018-04-01 to 2018-09-30867,499USD183

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2019-04-01 to 2019-09-3028,338USD183
2018-04-01 to 2018-09-309,656USD183

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2019-04-01 to 2019-09-30152,492USD183
2018-04-01 to 2018-09-300USD183

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2019-04-01 to 2019-09-30170,371USD183
2018-04-01 to 2018-09-300USD183

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2019-04-01 to 2019-09-3059,010USD183
2018-04-01 to 2018-09-305,355USD183

Inspect the source

Entity
NEMAURA MEDICAL INC. / CIK 0001602078
Captured
SEC response SHA-256
3af4f00449f095884d927b68ab2fc6d79dd5add77d667bb50f3822178e742afd

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001602078.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))